- EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG
- EQS-News: Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
- EQS-News: Eckert & Ziegler and UJF Open State-of-the-Art Actinium-225 Production Facility
- EQS-News: Eckert & Ziegler Hosts Second Radionuclide Theranostics Forum in Boston, MA
- EQS-News: Eckert & Ziegler receives “Best Managed Companies Award”
- EQS-News: Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
- EQS-Adhoc: Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.
More ▼
Key statistics
As of last trade Eckert & Ziegler SE (EUZ:STU) traded at 45.96, -7.11% below its 52-week high of 49.48, set on Jun 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 46.02 |
---|---|
High | 46.82 |
Low | 45.82 |
Bid | 45.94 |
Offer | 46.14 |
Previous close | 46.00 |
Average volume | 1.47k |
---|---|
Shares outstanding | 21.17m |
Free float | 14.53m |
P/E (TTM) | 27.96 |
Market cap | 974.76m EUR |
EPS (TTM) | 1.65 EUR |
Annual div (ADY) | 0.05 EUR |
---|---|
Annual div yield (ADY) | 0.11% |
Div ex-date | Jun 27 2024 |
Div pay-date | Jul 01 2024 |
Data delayed at least 15 minutes, as of Jul 05 2024.
More ▼